These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5155559)

  • 1. [Study of anti-Au antibodies in polytransfused thalassemic patients].
    Moscatelli P; Burlando L; Sciarratta GV
    Pathologica; 1971; 63(925):275-9. PubMed ID: 5155559
    [No Abstract]   [Full Text] [Related]  

  • 2. The incidence of hepatitis-associated antigen and antibody in patients with thalassaemia in Greece.
    Economidou J; Constantoulakis M; Augustaki O; Taylor PE; Zuckerman AJ; Baines PM; Bryceson MA
    Vox Sang; 1970; 19(3):401-3. PubMed ID: 4993791
    [No Abstract]   [Full Text] [Related]  

  • 3. [Incidence of Australia antigen (HB Ag) and its related antibody (HB Ab) in Siciliam thalassemic children treated with multiple transfusions].
    Musumeci S; Di Gregorio F; Marino S; Fischer A; Pizzarelli G
    Pediatria (Napoli); 1977 Mar; 85(1):21-33. PubMed ID: 876745
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence of Au-Ag and Au-Ab in transfused children with thalassaemia in Greece.
    Kattamis C; Syriopoulou V; Davri-Karamouzi Y; Demetriou D; Matsaniotis N
    Arch Dis Child; 1974 Jun; 49(6):450-3. PubMed ID: 4853764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of hepatitis-B virus markers in multi-transfused thalassemic patients.
    Mital MK; Vij JC; Talukdar B; Sachdev HP; Saini L
    Indian Pediatr; 1988 Feb; 25(2):161-5. PubMed ID: 3246395
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunologic markers of type B viral hepatitis in patients with homozygote transfusion-dependent beta-thalassemia].
    Del Poeta G; Masi M
    Recenti Prog Med; 1983 Sep; 74(9):999-1011. PubMed ID: 6658174
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prevalence of hepatitis A antibodies in polytransfused thalassemic patients].
    Mangiagli A
    Pediatr Med Chir; 1997; 19(6):437-8. PubMed ID: 9595581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genetic relationships of Australia antigen.
    London WT
    Vox Sang; 1973; 24():Suppl:1-7. PubMed ID: 4124190
    [No Abstract]   [Full Text] [Related]  

  • 9. The prevalence of hepatitis C virus antibodies in thalassemic patients in the south of Thailand.
    Laosombat V; Pornpatkul M; Wongchanchailert M; Worachat K; Wiriyasatienku A
    Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):149-53. PubMed ID: 9322298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of hepatitis B vaccine in multi-transfused thalassemic patients with and without hepatitis C infection: a comparative study with healthy controls.
    Froutan-Pishbijari H; Ghofrani H; Mirmomenm S; Kazemi-Asl S; Nassiri-Toosi M; Farahvash MJ; Toroghi HH; Aminian K; Mansour-Ghanaei F; Bagherzadeh AH
    Med Sci Monit; 2004 Dec; 10(12):CR679-83. PubMed ID: 15567986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocyte antibodies in thalassemic patients.
    Sujirachato K; Chiewsilp P; Isarangkura P
    Birth Defects Orig Artic Ser; 1988; 23(5B):283-5. PubMed ID: 3390553
    [No Abstract]   [Full Text] [Related]  

  • 12. HLA class I antibodies in thalassemic patients.
    Nathalang O; Torcharus K; Chuansumrit A; Punyaprasiddhi P; Sriphaisal T; Tatsumi N
    Southeast Asian J Trop Med Public Health; 1998 Dec; 29(4):801-4. PubMed ID: 10772568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody against hepatitis associated antigen (H.A.A.) in children with thalassemia and the risk of posttransfusion hepatitis.
    Pongpipat D; Suvatte V; Ratanawong A
    J Med Assoc Thai; 1973 Jun; 56(6):341-6. PubMed ID: 4784773
    [No Abstract]   [Full Text] [Related]  

  • 14. [Importance of Australia antigen determination in patients with multiple transfusions].
    Sandu L; Milcov V; Babeş V
    Chirurgia (1951); 1973 Dec; 22(12):1123-7. PubMed ID: 4775046
    [No Abstract]   [Full Text] [Related]  

  • 15. Australia antigen (HBsAg) in thallassemia children receiving multiple transfusions.
    Mehta KP; Patil HL; Merchant SM; Babar ST; Baxi AJ; Bapat JP
    Indian Pediatr; 1977 Jun; 14(6):455-9. PubMed ID: 604273
    [No Abstract]   [Full Text] [Related]  

  • 16. Australia antigen and hepatitis: recent observations on the serum protein polymorphism, infectious agent hypotheses.
    London WT; Sutnick AI; Millman I; Coyne V; Blumberg BS; Vierucci A
    Can Med Assoc J; 1972 Feb; 106(Spec Issue):Suppl:480-5. PubMed ID: 4552631
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibodies to hepatitis C virus in thalassemia.
    Angelucci E
    Haematologica; 1994; 79(4):353-5. PubMed ID: 7528705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum lipids and their modifications after blood transfusion in polytransfused beta-thalassemic patients.
    Leonardi S; Colianni R; Fischer A; Curreri R; Di Gregorio F; Pizzarelli G; Musumeci S
    Haematologica; 1988; 73(4):269-71. PubMed ID: 3139529
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevalence of anti HCV, HBsAg and HIV antibodies in high risk recipients of blood and blood products.
    Chakrabarti S; Pradhan P; Roy A; Hira M; Bandyopadhyay G; Bhattacharya DK
    Indian J Public Health; 2006; 50(1):43-4. PubMed ID: 17193761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum hepatitis from the viewpoint of Au-SH antigen studies].
    Wewalka F
    Bibl Haematol; 1971; 37():235-42. PubMed ID: 5138909
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.